These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10624478)

  • 41. Focal and asymmetric cortical degenerative syndromes.
    Caselli RJ
    Adv Neurol; 2000; 82():35-51. PubMed ID: 10624469
    [No Abstract]   [Full Text] [Related]  

  • 42. [A case of corticobasal degeneration of which movemental disturbances were improved by administration of amantadine].
    Yasuoka T; Ikeda M; Maki N; Hokoishi K; Komori K; Tanabe H
    No To Shinkei; 2001 Aug; 53(8):781-5. PubMed ID: 11577423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The deficit for the word-class "verb" in corticobasal degeneration: linguistic expression of the movement disorder?
    Silveri MC; Ciccarelli N
    Neuropsychologia; 2007 Jun; 45(11):2570-9. PubMed ID: 17467749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review.
    Tashiro K; Ogata K; Goto Y; Taniwaki T; Okayama A; Kira J; Tobimatsu S
    Clin Neurophysiol; 2006 Oct; 117(10):2236-42. PubMed ID: 16920021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Autopsy case of atypical type of alzheimer's disease clinically diagnosed as corticobasal degeneration].
    Osako M; Mochizuki Y; Kugio Y; Mizutani T; Hayashi H
    Rinsho Shinkeigaku; 2007 Sep; 47(9):581-4. PubMed ID: 18018616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Speech and swallowing disturbances in corticobasal degeneration.
    Frattali CM; Sonies BC
    Adv Neurol; 2000; 82():153-60. PubMed ID: 10624479
    [No Abstract]   [Full Text] [Related]  

  • 47. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
    Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
    J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional imaging studies in corticobasal degeneration.
    Brooks DJ
    Adv Neurol; 2000; 82():209-15. PubMed ID: 10624484
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased CSF tau protein in corticobasal degeneration.
    Mitani K; Furiya Y; Uchihara T; Ishii K; Yamanouchi H; Mizusawa H; Mori H
    J Neurol; 1998 Jan; 245(1):44-6. PubMed ID: 9457628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corticobasal degeneration look-alikes.
    Bhatia KP; Lee MS; Rinne JO; Revesz T; Scaravilli F; Davies L; Marsden CD
    Adv Neurol; 2000; 82():169-82. PubMed ID: 10624481
    [No Abstract]   [Full Text] [Related]  

  • 51. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.
    Cotelli M; Borroni B; Manenti R; Alberici A; Calabria M; Agosti C; Arévalo A; Ginex V; Ortelli P; Binetti G; Zanetti O; Padovani A; Cappa SF
    Neuropsychology; 2006 Sep; 20(5):558-65. PubMed ID: 16938018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration.
    Grossman M; McMillan C; Moore P; Ding L; Glosser G; Work M; Gee J
    Brain; 2004 Mar; 127(Pt 3):628-49. PubMed ID: 14761903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychiatric consequences of basal ganglia disease.
    Rogers D
    Semin Neurol; 1990 Sep; 10(3):262-6. PubMed ID: 2259804
    [No Abstract]   [Full Text] [Related]  

  • 55. Psychiatric aspects of basal ganglia diseases.
    Vlastelica M
    Psychiatr Danub; 2011 Jun; 23(2):152-6. PubMed ID: 21685853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved Mobility, Cognition, and Disease Severity in Corticobasal Degeneration of an African American Man After 12 Weeks of Adapted Tango: A Case Study.
    Silverstein HA; Hart AR; Bozorg A; Hackney ME
    Am J Phys Med Rehabil; 2020 Feb; 99(2):e21-e27. PubMed ID: 30801264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Executive control functions and neuropsychiatric disorders -- perspectives for research und clinical practice].
    Kaiser S; Mundt C; Weisbrod M
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):438-50. PubMed ID: 16052438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evolution and treatment of neuropsychiatric disorders in a case of hypoparathyroidism diagnosed late].
    Sabbatini F; Isaia GC; Angelini G; Amedeo G; Ciccarelli E; Mussetta M
    Minerva Psichiatr; 1983; 24(3):103-7. PubMed ID: 6668995
    [No Abstract]   [Full Text] [Related]  

  • 59. Corticobasal degeneration with hippocampal involvement.
    Kobayashi K; Fukutani Y; Miyazu K; Arai N
    Clin Neuropathol; 1999; 18(2):106-8. PubMed ID: 10192707
    [No Abstract]   [Full Text] [Related]  

  • 60. Epidemiologic aspects.
    Togasaki DM; Tanner CM
    Adv Neurol; 2000; 82():53-9. PubMed ID: 10624470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.